IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is a multicenter, double-blind, randomized placebo controlled, parallel group,
superiority trial in order to test the superiority of intramuscular injections of
IncobotulinumtoxinA against placebo using a 1:1 allocation ratio.